Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma

NCT00553306 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Melanoma
Stage IV Melanoma

Interventions

BIOLOGICAL: therapeutic autologous lymphocytes
BIOLOGICAL: aldesleukin
DRUG: cyclophosphamide
PROCEDURE: biopsy
OTHER: immunohistochemistry staining method
OTHER: flow cytometry
GENETIC: polymerase chain reaction

Sponsor

Fred Hutchinson Cancer Center